The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

Pharmaceutical manufacturer Sigachi Industries has announced a 10 per cent final dividend for FY25 after posting a strong Q4 ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

Discover the latest in pharmaceutical outsourcing with The Bio/Pharmaceutical Outsourcing Report. Gain insights into CMO trends, new contracts, mergers, and more. Essential for CMO executives, ...

The Global Biologics CDMO Market is expected to witness a growth rate of 14-16% in the next five years. Growing ...

The Brazil Veterinary Medicine Market, valued at USD 2.65 Billion in 2024, is projected to reach USD 4.15 Billion by 2030, ...

Hyderabad: Aurobindo Pharma has announced that Curateq Biologics Private Limited, a wholly owned subsidiary of the Company, ...

Research news last week included Rocket Pharmaceuticals suffering a setback with its Phase II trial of RP-A501, which ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

In a bid to allay conflict-of-interest concerns, Korean manufacturing giant Samsung Biologics is decoupling from its ...

No. of COVID-19 Cases Hikes, Triggering Speculation in Related Pharma; CSPC PHARMA/ JUNSHI BIO/ SIMCERE PHARMA/ BRII-B Surge ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...